Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apeiron Center for Human Potential is a precision medicine and human performance organization that utilizes a systems-biology approach to optimize health and longevity. Founded by Dr. Daniel Stickler and Mickra Hamilton, the center integrates advanced genomics, epigenetics, and comprehensive physiological data to create highly personalized health protocols. Their services range from clinical consultations and executive performance coaching to specialized programs for metabolic and cognitive optimization. Additionally, the organization operates the Apeiron Academy, which provides evidence-based training for healthcare professionals in the field of applied human genomics. By shifting the focus from disease management to peak performance, Apeiron Center aims to redefine the standards of proactive healthcare and human potential. The center's methodology emphasizes the dynamic interaction between genetics and environment to drive sustainable biological enhancement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apeiron Center.